Results 11 to 20 of about 452,650 (302)

The clinical and economic burden of community-onset complicated skin and skin structure infections in Korea [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims To investigate epidemiologic characteristics, clinical and economic burdens, and factors associated with mortality in complicated skin and skin structure infection (cSSSI) patients in Korea.
Yong Kyun Cho, Heung Jeong Woo, Shin Woo Kim, In-Gyu Bae, Young Goo Song, Hee Jin Cheong, Hyuck Lee, Sang Hoon Han, Hee Jung Choi, Chisook Moon, Seong Yeol Ryu, Jian Hur, Ja Cob Lee, Yu Mi Jo, Young Joo Kim   +14 more
doaj   +1 more source

Efficacy and safety of dalbavancin in the treatment of Gram-positive bacterial infections

Journal of Global Antimicrobial Resistance, 2021
Objectives: In this meta-analysis, we assessed the clinical efficacy and safety of dalbavancin compared with commonly used anti-Gram-positive agents. Methods: PubMed, Embase and Cochrane Library databases were searched from inception up to 25 February ...
Yuhang Wang, Jin Wang, Rui Wang, Yuanyuan Li, Yun Cai   +4 more
doaj   +1 more source

Ceftaroline in complicated skin and skin-structure infections

Infection and Drug Resistance, 2012
Ceftaroline is an advanced-generation cephalosporin antibiotic recently approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure infections (cSSSIs). This intravenous broad-spectrum antibiotic exerts potent bactericidal activity by inhibiting bacterial cell wall synthesis.
Hernandez, Paul O, Lema, Sergio, Tyring, Stephen K, Mendoza, Natalia   +3 more
  +8 more sources

Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence [PDF]

, 2014
Peer reviewedPublisher ...
A Di Pietro, A Reuben, AL Martinez-Rocha, Antonio Di Pietro, B Musher, BE de Pauw, CS Foster, CY Low, David R. Andes, DB Jones, DC Sheppard, Donna MacCallum, E Anaissie, E Mayayo, EI Boutati, FC Odds, FM Polack, FP Silveira, GM Gonzalez, GP Bodey, HC Gugnani, IL Stevenson, J Guarro, KA Marr, Katja Schäfer, M Nucci, M Nucci, M Nucci, M Ortoneda, MC Dignani, MJ Bharathi, MS Lopez-Berges, MS Lopez-Berges, NA Rotowa, Neil A. R. Gow, PE Nelson, PE Nelson, RC Prados-Rosales, TF Patterson, TJ Liesegang, TJ Walsh, Y Couteaudier, Y Fan, Y Ishibashi, Y Kono, Y Zhao   +45 more
core   +8 more sources

Efficacy and safety of oritavancin for the treatment of acute bacterial skin and skin-structure infections: a systematic review and meta-analysis

Journal of Global Antimicrobial Resistance, 2021
: Objectives: This study aimed to evaluate the efficacy and safety of oritavancin (ORI) versus comparators for the treatment of acute bacterial skin and skin-structure infections (ABSSSIs) based on available clinical studies.
Huan Zhang, Weiying Zhou, Jin Wang, Yun Cai   +3 more
doaj   +1 more source

Oritavancin for acute bacterial skin and skin structure infections [PDF]

Expert Opinion on Pharmacotherapy, 2015
Inpatient treatment of acute bacterial skin and skin structure infections (ABSSSIs) exerts a significant economic burden on the healthcare system. Oritavancin is a concentration-dependent, rapid bactericidal agent approved for the treatment of ABSSSIs.
Julia A, Messina, Vance G, Fowler, G Ralph, Corey   +2 more
openaire   +2 more sources

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

BMC Infectious Diseases, 2012
Background Complicated skin and skin structure infections (cSSSIs) frequently result in hospitalization with significant morbidity and mortality. Methods In this phase 3b/4 parallel, randomized, open-label, comparative study, 531 subjects with cSSSI ...
Matthews Peter, Alpert Marc, Rahav Galia, Rill Denise, Zito Edward, Gardiner David, Pedersen Ron, Babinchak Timothy, McGovern Paul C   +8 more
doaj   +1 more source

A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice

Antibiotics, 2022
The antibiotic dalbavancin is approved for intravenous treatment of adults with acute bacterial skin and skin structure infections. This study aimed to observe the use, effectiveness, and safety of dalbavancin in clinical practice in Germany.
Frank Hanses, Sebastian Dolff, Janina Trauth, Michael Seimetz, Stefan Hagel   +4 more
doaj   +1 more source

Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis

Journal of Infection and Public Health, 2023
Background: The treatment of acute bacterial skin and skin structure infections (ABSSSI) usually involves intravenous (i.v.) antibiotics requiring hospitalisation and increasing hospital costs.
Christoph T. Baltin, Carolin Wulf, Robert Rongisch, Clara Lehmann, Sebastian Wingen-Heimann, Nicole Eisenmenger, Jennifer Bonn, Mario Fabri, Esther von Stebut, Oliver A. Cornely, Florian Kron   +10 more
doaj   +1 more source

Washeteria closures, infectious disease and community health in rural Alaska: a review of clinical data in Kivalina, Alaska [PDF]

, 2013
Background. Kivalina is a northwest Alaska barrier island village of 400 people vulnerable to storm surges exacerbated recently by delayed winter sea and shore ice formation. The village has no in-home piped water or sewage; the “washeteria”
Dana Bruden, Jake Bell, Michael Brubaker, Millie Hawley, Timothy K. Thomas   +4 more
core   +1 more source